TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/24 16:37 | 12/3/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | S | -1 | 2.08 | 0 | -1 | 0 | 133 | D | ||||||||||||||
9/6/24 16:20 | 9/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | S | -2 | 3.42 | 0 | -1 | 0 | 134 | D | ||||||||||||||
7/22/24 17:01 | 7/19/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | S | -34 | 5.21 | 0 | -7 | -5 | 134 | D | ||||||||||||||
6/6/24 16:16 | 6/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | S | -3 | 5.50 | 0 | -1 | 0 | 141 | D | ||||||||||||||
3/5/24 19:54 | 3/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | SVP,CHIE | S.d | -191 | 9.42 | 0 | -20 | -13 | 142 | D | ||||||||||||||
7/21/23 16:30 | 7/19/23 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | SVP,CHIE | S | -38 | 8.80 | 0 | -4 | -6 | 72 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |